Speakers
Leadership & Management
Room: Carlton Room
Laboratory Medicine is even more vital to healthcare following the impact of the pandemic. This session will ask:
Bernie Croal 10:30 – 11:00 The importance of Labs in Recovery
Ian Frayling 11:00 – 11:30 Long Covid
Ian qualified in Clinical Medicine at Cambridge in 1982, initially trained in Chemical Pathology then moved into genetics, specifically hereditary cancer. He was the only Genetic Pathologist in NHS service until his retirement from NHS Wales in 2019. He is now President of the Association of Clinical Pathologists and Honorary Consulting Genetic Pathologist to the National Centres for Colorectal Disease in the UK (St Mark’s, Harrow) and Ireland (St Vincent’s, Dublin), as well as an Honorary Senior Clinical Research Fellow in the Inherited Tumour Syndromes Research Group in the Institute of Cancer & Genetics at Cardiff University.
In addition, Ian holds many other positions, including being an assessor for the UK National External Quality Assessment Scheme for Immunocytochemistry & ISH; a Member of Council of the International Society for Gastrointestinal Hereditary Tumours (InSiGHT); a Member of Council of the UK Cancer Genetics Group; an Honorary Medical Advisor to Lynch Syndrome UK & Lynch Syndrome Ireland; and is a member of the Union of European Medical Specialists (UEMS) Board of Laboratory Medicine.
Ian has been conferred with the rare distinction of Honorary Fellowship of the Faculty of Pathology of the Royal College of Physicians of Ireland, and is a recipient of both the Association of Clinical Pathologists’ Dyke Foundation Medal for his “eminence as a member of the pathology community” and the Pathological Society of Great Britain & Ireland’s Goudie Medal for his “seminal contribution to the science of pathology.” His publication record includes over 80 peer-reviewed papers, with approximately 8,000 citations and an H-index of 40, plus 70 other publications, including the WHO Classification of Tumours series. Ian helped establish National Institute for Health & Care Excellence (NICE) Diagnostics Guidance DG27 and later DG42, that all incident bowel and now endometrial cancers must be tested to see if they are due to Lynch syndrome. However, Ian is now a patient himself suffering from LongCovid since April 2020, and becoming a co-founder of the patient group LongCovidWales. So, more recently, as an informed expert patient, he has provided input into both NICE and WHO LongCovid guidance, as well as participating as a subject in numerous research studies.